Psychiatry & Neurology, Forensic Psychiatry · Houston, TX
NPI
1558342956
Since 2005
Specialty
Psychiatry & Neurology, Forensic Psychiatry
Code 2084F0202X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
820 Gessner Rd, #750
Houston, TX, 77024
Phone (713) 973-1007
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$666K
4,051 prescriptions
Company payments, 2025
$1,873
From 18 companies
Medicare prescription drug claims, 2024
In 2024, the drug Karen S Brown prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 291 prescriptions and refills. In total Karen S Brown wrote 4,051 Medicare prescriptions that cost $666K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Bupropion Xl Bupropion Hcl | 291 | 519 | 55 | $7,610 |
| Duloxetine Hcl Generic | 259 | 455 | 47 | $5,709 |
| Quetiapine Fumarate Generic | 240 | 450 | 45 | $6,058 |
| Clonazepam Generic | 237 | 264 | 45 | $2,425 |
| Lithium Carbonate Generic | 228 | 330 | 37 | $1,447 |
| Alprazolam Generic | 225 | 249 | 40 | $1,671 |
| Lorazepam Generic | 196 | 211 | 32 | $1,146 |
| Lamotrigine Generic | 190 | 341 | 34 | $3,352 |
| Escitalopram Oxalate Generic | 156 | 269 | 31 | $1,712 |
| Lithium Carbonate Er Lithium Carbonate | 129 | 206 | 20 | $1,461 |
| Mirtazapine Generic | 128 | 228 | 24 | $2,699 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 110 | 110 | 15 | $2,622 |
| Trazodone Hcl Generic | 106 | 192 | 20 | $960 |
| Aripiprazole Generic | 102 | 174 | 25 | $2,371 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 92 | 218 | 20 | $6,186 |
Brand drugs: 372 claims; generic drugs: 3,679 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen S Brown $1,873 ($1,873 in general payments such as food, travel and fees) from 18 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $280.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $280 |
| Abbvie Inc. ABBV | 14 | $246 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $202 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $190 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $178 |
| Corium, LLC | 5 | $147 |
| Alkermes, Inc. ALKS | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $65.35 |
| Axsome Therapeutics, Inc. AXSM | 3 | $62.19 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $60.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.